Stone X Group Inc. Moderna, Inc. Transaction History

Stone X Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$117.13 - $176.59 $157,305 - $237,160	-1,343 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$126.46 - $235.05 $22,636 - $42,073	179 Added 15.38%	1,343 $231,000
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $18,517 - $30,217	82 Added 7.58%	1,164 $296,000
Q3 2021 Oct 20, 2021	SELL	$221.9 - $484.47 $45,711 - $99,800	-206 Reduced 15.99%	1,082 $416,000
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $167,324 - $302,654	1,288 New	1,288 $303,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

Stay updated on Stone X Group Inc. with notifications on news.